Document is current
Any future updates will be listed below
-
Authors
Elder, Nicholas H.
Majd, Alireza https://orcid.org/0000-0003-0036-2725
Cesiulis, Andrius
Nyarady, Spencer
Sankar, Kalyan
Bulger, Emily A. https://orcid.org/0000-0003-2967-1994
Samuel, Ryan M.
Zholudeva, Lyandysha V.
McDevitt, Todd C.
Fattahi, Faranak https://orcid.org/0000-0002-9473-8596
-
Funding
Funding for this research was provided by:
California Institute for Regenerative Medicine (DISC0-14521)
California Institute for Regenerative Medicine (DISC2-15119)
California Institute for Regenerative Medicine (DISC2-16715)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK142437)
- License Information
-
More Information
Article History
Received: 6 January 2025
Accepted: 16 July 2026
First Online: 29 July 2026
Ethics
Competing interests: N.H.E. is an employee of Cellanome and inventor on a patent application owned by Cellanome. E.A.B. is an employee of Genentech. T.C.M. is an advisor for Vitra Labs. F.F. is an inventor of several patent applications owned by UCSF, MSKCC and Weill Cornell Medicine related to hPSC-differentiation technologies, including technologies for derivation of neural cells, their derivatives and their application for drug discovery. F.F. is also a scientific co-founder and advisor of EverTree Bio and serves as a paid consultant for Cellanome. The work presented here is not related to the interests of these commercial entities.
